|Bid||0.4350 x 0|
|Ask||0.4600 x 0|
|Day's Range||0.4600 - 0.4600|
|52 Week Range||0.1350 - 0.6500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Pharmaceutical- Grade Hand Sanitizer Receives Dermatologists' Seal of ApprovalVANCOUVER, BC / ACCESSWIRE / July 23, 2020 / (CSE:OVAT) - Ovation Science Inc.
The results of the controlled laboratory testing showed that DermSafe demonstrated a 99.97% reduction in active viral loads at two time points. The purpose of the study was to evaluate the ability of Ovation's DermSafe hand sanitizer to kill a human beta coronavirus strain. The study verified the effectiveness of DermSafe hand sanitizer made with chlorhexidine gluconate to kill a human beta coronavirus at time points of 1 and 5 minutes.
Ovation's new distributor, Grupo Venta International, S.A. de C.V. ("Grupo Venta"), with corporate offices in Guadalajara, Mexico, has made their first purchase of over 10,000 bottles of DermSafe, which they will begin distributing through-out Mexico. DermSafe® is a pharmaceutical-grade hand sanitizer lotion that uses chlorhexidine gluconate; an ingredient used worldwide in hospitals as it has a proven ability to kill germs.